SG11202110423UA - Anesthetic composition and method of anesthetizing the eye - Google Patents

Anesthetic composition and method of anesthetizing the eye

Info

Publication number
SG11202110423UA
SG11202110423UA SG11202110423UA SG11202110423UA SG11202110423UA SG 11202110423U A SG11202110423U A SG 11202110423UA SG 11202110423U A SG11202110423U A SG 11202110423UA SG 11202110423U A SG11202110423U A SG 11202110423UA SG 11202110423U A SG11202110423U A SG 11202110423UA
Authority
SG
Singapore
Prior art keywords
anesthetizing
eye
anesthetic composition
anesthetic
composition
Prior art date
Application number
SG11202110423UA
Inventor
Martin Uram
Original Assignee
Martin Uram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/024239 external-priority patent/WO2019191200A1/en
Application filed by Martin Uram filed Critical Martin Uram
Publication of SG11202110423UA publication Critical patent/SG11202110423UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202110423UA 2019-03-26 2020-03-16 Anesthetic composition and method of anesthetizing the eye SG11202110423UA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962824207P 2019-03-26 2019-03-26
PCT/US2019/024239 WO2019191200A1 (en) 2018-03-27 2019-03-27 Method and formulation for producing anesthesia of internal aspect of eye wall by topical application
US16/811,798 US11096922B2 (en) 2018-03-27 2020-03-06 Anesthetic composition and method of anesthetizing the eye
PCT/US2020/022915 WO2020197816A1 (en) 2019-03-26 2020-03-16 Anesthetic composition and method of anesthetizing the eye

Publications (1)

Publication Number Publication Date
SG11202110423UA true SG11202110423UA (en) 2021-10-28

Family

ID=72609654

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202110423UA SG11202110423UA (en) 2019-03-26 2020-03-16 Anesthetic composition and method of anesthetizing the eye

Country Status (11)

Country Link
EP (1) EP3946311A4 (en)
JP (1) JP2022527621A (en)
KR (1) KR20210143254A (en)
CN (1) CN114072139A (en)
AU (1) AU2020245203A1 (en)
BR (1) BR112021019039A2 (en)
CA (1) CA3134531A1 (en)
IL (1) IL286624A (en)
MX (1) MX2021011589A (en)
SG (1) SG11202110423UA (en)
WO (1) WO2020197816A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2132826C (en) * 1992-05-06 1999-01-05 Masood Chowhan Use of borate-polyol complexes in ophthalmic compositions
ATE547122T1 (en) * 2001-11-21 2012-03-15 Novartis Pharma Gmbh COMPOSITION FOR STABILIZING HYALURONIC ACID
CN101695488B (en) * 2009-11-05 2012-05-02 蚌埠丰原涂山制药有限公司 Compound articaine freeze-drying preparation for injection and preparation method thereof
CN101721407B (en) * 2009-11-23 2013-04-10 蚌埠丰原涂山制药有限公司 Compound articaine hydrochloride injection and preparation method thereof
FR2968996B1 (en) * 2010-12-17 2013-04-12 Anteis Sa AQUEOUS INJECTABLE STERILE FORMULATION USED IN OPHTHALMOLOGY
FR3036035B1 (en) * 2015-05-11 2018-10-05 Laboratoires Vivacy COMPOSITIONS COMPRISING AT LEAST ONE POLYOL AND AT LEAST ONE ANESTHETIC
JP2018526423A (en) * 2015-09-08 2018-09-13 ビューポイント セラピューティクス, インコーポレイテッド Compounds and formulations for treating ophthalmic diseases
WO2018220283A1 (en) * 2017-05-29 2018-12-06 Kh Medtech Sarl Sterile injectable composition containing cross-linked hyaluronic acid and articaine

Also Published As

Publication number Publication date
IL286624A (en) 2021-10-31
JP2022527621A (en) 2022-06-02
MX2021011589A (en) 2021-12-15
AU2020245203A1 (en) 2021-11-11
BR112021019039A2 (en) 2021-11-30
EP3946311A1 (en) 2022-02-09
WO2020197816A1 (en) 2020-10-01
KR20210143254A (en) 2021-11-26
EP3946311A4 (en) 2022-12-28
CN114072139A (en) 2022-02-18
CA3134531A1 (en) 2020-10-01

Similar Documents

Publication Publication Date Title
IL283905A (en) Methods and compositions for delivery of carbon dioxide
IL283840A (en) Compositions for the delivery of therapeutic agents and methods of use and making thereof
IL287720A (en) Modulators of thr-beta and methods of use thereof
IL282600A (en) Composition and method for treating the lungs
IL273959A (en) Methods and compositions for the treatment of rare diseases
IL276247A (en) Methods and compositions for treating sleep apnea
IL292810A (en) Therapeutic compounds and methods of use
IL287966A (en) Auto-injector and related methods of use
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
IL285197A (en) Methods and compositions for treating sleep apnea
LT3675816T (en) Sustained-release anesthetic compositions and methods of preparation thereof
SG11202100533VA (en) Hepato-biliary-pancreatic tissues and methods of making same
IL284082A (en) Silk-hyaluronic acid tissue fillers and methods of making and using the same
IL286697A (en) Neuregulin-4 compounds and methods of use
IL287829A (en) Progranulin modulators and methods of using the same
IL277156A (en) Compositions and methods for treatment of insulin resistance
IL286624A (en) Anesthetic composition and method of anesthetizing the eye
SG11202113333SA (en) Compounds and methods of use
GB2579687B (en) Composition and method
GB201914777D0 (en) Composition and method
EP3875135A4 (en) Anesthesia respiration device and method
GB2603379B (en) Avocatin B for the treatment of diseases and conditions
IL282671A (en) Therapeutic methods and compositions
IL290548A (en) Bacteria and methods of use thereof
AU2019900514A0 (en) Compositions and methods for treating respiratory diseases